This trial is evaluating whether CDS Tool Access will improve 2 primary outcomes and 3 secondary outcomes in patients with Diabetes Mellitus, Type 2. Measurement will happen over the course of 12 months; in secondary analyses, we will do repeated cross-sectional analysis using 6-, 12-, and 18-month data.
This trial requires 60 total participants across 2 different treatment groups
This trial involves 2 different treatments. CDS Tool Access is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"Diabetes is a serious illness that contributes to health problems in an individual and their family. Approximately one-third of Canadians older than 15 years have [type 2 diabetes](https://www.withpower.com/clinical-trials/type-2-diabetes) and it causes a significant increase in the risk of cardiovascular disease and death.\n" - Anonymous Online Contributor
"The incidence of diabetes mellitus, type 2, increased substantially in the period between 1976 and 1999, for both whites and blacks. The proportion of whites and blacks diagnosed with diabetes fell. [About] 90% of the whites and blacks had access to medical care. There were major racial differences in the proportion of whites and blacks receiving primary preventive care, but the proportion of blacks and whites receiving secondary preventive intervention, such as blood pressure checks and lipid treatment, did not vary by race." - Anonymous Online Contributor
"Signs can be mistaken for symptoms. The health care doctor should be aware of certain signs that can be found in individuals with diabetes mellitus, type 2. Diabetes mellitus, type 2 can be managed through a healthy diet, regular physical activity, and regular screening for signs and symptoms. Treat patients who have a BMI of greater than or equal to 25 kg/m2 without proper cause." - Anonymous Online Contributor
"It cannot be cured as currently treated with medications. It depends on the combination of medications and the individual. Further studies are needed to develop a good combination." - Anonymous Online Contributor
"Obesity and a high-fat diet are thought to increase the risk of developing diabetes mellitus type-2. Furthermore, stress is suspected to be a causal factor. For those at low risk, however, it is not known whether the risk of developing diabetes is increased. Further research needs to be conducted to determine whether the increased risk of type 2 diabetes could be prevented with lifestyle changes." - Anonymous Online Contributor
"While the majority of patients for whom therapy was indicated used oral agents, there is no difference in duration of treatment for those who use alternative agents such as metformin and sulfonylureas. As for those with a prior history of heart failure or a history of cardiovascular disease, the superiority of oral agents is not established." - Anonymous Online Contributor
"Cds-tool access was associated with the prescription of drug therapies that could potentially lower insulin requirements. Moreover, access to cds-tool and access to the CDSC might be useful predictors of future clinical outcomes that could improve patient clinical outcomes." - Anonymous Online Contributor
"CDS tool access was associated with significantly improved self-reported HRQOL for patients with type 2 diabetes. The tool is widely understood and is readily available, however, there were no changes in clinical outcomes related to treatment changes." - Anonymous Online Contributor
"Results from a recent clinical trial demonstrated how to use the Cds tool on paper sheets and how to integrate the tool function to enable real-time and contextual access for clinical documentation." - Anonymous Online Contributor
"The average age of onset of diabetes was 51.7 years, which is different from the age of onset of diabetes, type 1, which is most commonly in children ages 5 to 9 years. The age-specific prevalences of diabetes mellitus, type 2, in the U.S. population were 2.6% in women and 3.8% in men, respectively." - Anonymous Online Contributor
"The CDS tool has undergone further development. We found that several areas need attention: Improved development of interfaces to support patients, development of a workflow to improve the user experience, validation of the tool’s use in clinical practice, enhanced guidance for clinicians, and user interface improvements. The tool's use in clinical practice was assessed using usability and patient acceptance instruments, which were designed for that specific use. For example, we used a tool tailored to assist patients with diabetes in assessing their disease severity." - Anonymous Online Contributor
"Diabetics suffer major complications related to uncontrolled blood sugars; most significantly cardiovascular and neurological: coronary artery disease, peripheral vascular disease and strokes. A total of 29.3% of diabetic patients die from some form of cardiovascular disease. The majority of deaths occur due to uncontrolled blood sugars and other heart conditions. Diabetes mellitus, type 2 affects about 11% of adult Canadians. [Statistics Canada] is collaborating with Diabetes Ontario (DOO) to find data from health authorities throughout the province to analyze current trends and patterns in care for diabetic patients in Ontario. I am working with DOO to help people, in their own communities and in their own families, to understand the risk factors, cause and control for Diabetes mellitus, type 2 in Ontario." - Anonymous Online Contributor